Epigenomics AG products

High-quality cell-free DNA is easily and robustly purified from up to 3,5 ml of plasma. Streamlined procedure for fast and reliable results, Complete cytosine conversion, DNA extraction system for highly sensitive analysis

Colorectal cancer is curable in about 90% of cases if detected early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the industrialized world. Regular screening can prevent colorectal cancer. Epi proColon® offers a convenient way of detecting colorectal cancer: in blood. It’s as simple as a blood draw. The test is performed by a clinical laboratory. It detects a specific type of DNA called Septin9, which is altered in colorectal cancer tumor cells more often than in normal cells. Epi proColon® is the first and only FDA-approved blood-based test for the detection of colorectal cancer. The test is available in the United States, Europe, China and selected other countries.